From Türkiye to the World

Predictable, High-Quality Clinical Research Execution for Global Sponsors

Medex CRO delivers predictable, high-quality clinical trial execution in Türkiye for global pharmaceutical, biotechnology, and medical device companies.

We help sponsors reduce uncertainty, protect development timelines, and optimize clinical investment through structured planning, regulatory expertise, and strong investigator engagement.

Türkiye offers scientific depth, diverse patient populations, and a quality-driven research infrastructure — translated into controlled, transparent and reliable study execution.

Explore how we can support your next study

Türkiye offers strong potential for clinical research and Medex CRO elivers:

Through proactive planning and medically driven oversight, we ensure both scientific integrity and operational excellence.

Unlike purely operational CRO models, Medex CRO is physician-led. This structure strengthens endpoint integrity, participant safety, and inspection readiness.
Our medical leadership enables:

Successful clinical research depends on realistic planning. Medex maintains close collaboration with experienced investigators and high-quality clinical sites across Türkiye, enabling

Data-informed feasibility

Accurate patient recruitment projections

Sustainable site engagement

Reduced protocol deviations

Optimized enrollment timelines